Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People
暂无分享,去创建一个
H. Arai | S. Higuchi | Hidetada Sasaki | T. Matsui | H. Yao | T. Yuzuriha | S. Matsushita | Setsuko Hashimoto | A. Kato | M. Miura | M. Morikawa | Masatoshi Morikawa
[1] D. Ducloux,et al. Homocysteine in cerebral macroangiopathy and microangiopathy , 1999, The Lancet.
[2] G. Hankey,et al. Homocysteine and vascular disease , 1999, The Lancet.
[3] P. Wilson,et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.
[4] M. Hennerici,et al. Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.
[5] A J Marian,et al. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. , 1999, Stroke.
[6] E. Mori,et al. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. , 1999, Stroke.
[7] S. Ibayashi,et al. Decreased plasma tryptophan associated with deep white matter lesions in elderly subjects , 1999, Journal of neurology, neurosurgery, and psychiatry.
[8] R Clarke,et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.
[9] P. Chiusolo,et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. , 1998, Blood.
[10] S. Vollset,et al. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.
[11] I. Alfheim,et al. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. , 1998, Clinical chemistry.
[12] H. Bokura,et al. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study , 1998, Journal of Neurology.
[13] J. Spence,et al. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia , 1998, The Lancet.
[14] H. Bokura,et al. Subcortical silent brain infarction as a risk factor for clinical stroke. , 1997, Stroke.
[15] H. Markus,et al. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.
[16] R. Kronmal,et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1997, Stroke.
[17] K. Kario,et al. 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[18] S. Vollset,et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.
[19] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[20] M. Fujishima,et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. , 1995, Stroke.
[21] M. Matsumoto,et al. Asymptomatic Carotid Lesions and Silent Cerebral Infarction , 1994, Stroke.
[22] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[23] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[24] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .